Simply stated, a “meaningful interaction” between an HCP and a pharma sales rep is an exchange that results in an increased likelihood that the HCP will prescribe the product. This can only happen when a rep delivers value to an HCP, establishing themselves as a trusted advisor.
The industry has long surveyed HCPs to understand what they want from biopharma companies in an attempt to understand what makes a “meaningful interaction” with a rep. In a research study conducted in 2023,4 over 2000 HCPs in the US, EU5, and APAC were asked to indicate what drives an optimal customer experience with biopharma. In a long list of options, the top three drivers, in priority rank order, were: